article thumbnail

Take this test to predict your success:

Berkonomics

The dominant player in any niche controls pricing for all those under it, and often sets the risk profile for new entrants into the niche if the dominant player’s products or services fill the needs of customers at reasonable prices and quality. A core patent or “thicket” of patents protecting your offering?

Custom 156
article thumbnail

Can you guess 10 tests for your success?

Berkonomics

The dominant player in any niche controls pricing for all those under it, and often sets the risk profile for new entrants into the niche if the dominant player’s products or services fill the needs of customers at reasonable prices and quality. A core patent or “thicket” of patents protecting your offering?

Patents 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A heartbreaking story about time and money.

Berkonomics

And professional investors often penalize the company with lower-priced down rounds or expensive loans as a result. The company grew to be well known in this limited niche and was operating at slightly above breakeven, when the Board and CEO decided to seek venture investment from what we hoped would be a first tier VC firm in Silicon Valley.

article thumbnail

6 Mistakes Often Made Positioning Against Competition

Startup Professionals Musings

There is no perfect answer to the competitive advantage question, but investors are looking for how your offering will keep ahead of competition, not just at this moment, but throughout the life of their three to five-year investment. Leading with this answer will likely terminate any further investment opportunity with this investor.

article thumbnail

Here are ten vision tests for your success

Berkonomics

The dominant player in any niche controls pricing for all those under it, and often sets the risk profile for new entrants into the niche if the dominant player’s products or services fill the needs of customers at reasonable prices and quality. A core patent or “thicket” of patents protecting your offering?

Patents 291
article thumbnail

Financing with grants, not equity or debt

Berkonomics

I was chairman of a company that, for twelve years never took a dollar of outside investment. If you can finance your enterprise through grants rather than equity or debt, you retain control and when it is time to sell your interest in the business, a lower sales price will create a higher return on your personal investment.

Equity 156
article thumbnail

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

Xconomy

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. The patent holder, the University of Toronto, gave companies the right to manufacture insulin. to offer competitive pricing pressure. to offer competitive pricing pressure.

Patents 77